Nuvation Bio Inc (NUVB)
2.70
+0.08
(+3.05%)
USD |
NYSE |
Apr 26, 13:50
Nuvation Bio Total Assets (Quarterly): 621.48M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 621.48M |
| September 30, 2023 | 630.87M |
| June 30, 2023 | 641.41M |
| March 31, 2023 | 657.06M |
| December 31, 2022 | 672.14M |
| September 30, 2022 | 686.49M |
| June 30, 2022 | 719.74M |
| Date | Value |
|---|---|
| March 31, 2022 | 751.80M |
| December 31, 2021 | 776.15M |
| September 30, 2021 | 797.79M |
| June 30, 2021 | 814.26M |
| March 31, 2021 | 832.06M |
| December 31, 2020 | 221.79M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
221.79M
Minimum
Dec 2020
832.06M
Maximum
Mar 2021
678.70M
Average
686.49M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| iBio Inc | 34.02M |
| Flora Growth Corp | 23.63M |
| Lixte Biotechnology Holdings Inc | 4.309M |
| Replimune Group Inc | 532.93M |
| ABVC BioPharma Inc | 14.49M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.36M |
| Shareholders Equity (Quarterly) | 605.12M |